Angiotensin Receptor Antagonists
Angiotensin Receptor Antagonists market is segmented by region (country), players, by Type and by ... Read More
Global and United States Angiotensin Receptor Blockers (ARBs) Market Report & Forecast 2023-2028
1 Study Coverage
1.1 Angiotensin Receptor Blockers (ARBs) Product Introduction
1.2 Global Angiotensin Receptor Blockers (ARBs) Outlook 2017 VS 2022 VS 2028
1.2.1 Global Angiotensin Receptor Blockers (ARBs) Sales in US$ Million for the Year 2017-2028
1.2.2 Global Angiotensin Receptor Blockers (ARBs) Sales in Volume for the Year 2017-2028
1.3 United States Angiotensin Receptor Blockers (ARBs) Outlook 2017 VS 2022 VS 2028
1.3.1 United States Angiotensin Receptor Blockers (ARBs) Sales in US$ Million for the Year 2017-2028
1.3.2 United States Angiotensin Receptor Blockers (ARBs) Sales in Volume for the Year 2017-2028
1.4 Angiotensin Receptor Blockers (ARBs) Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Angiotensin Receptor Blockers (ARBs) in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Angiotensin Receptor Blockers (ARBs) Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Angiotensin Receptor Blockers (ARBs) Market Dynamics
1.5.1 Angiotensin Receptor Blockers (ARBs) Industry Trends
1.5.2 Angiotensin Receptor Blockers (ARBs) Market Drivers
1.5.3 Angiotensin Receptor Blockers (ARBs) Market Challenges
1.5.4 Angiotensin Receptor Blockers (ARBs) Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Angiotensin Receptor Blockers (ARBs) Market Segment by Type
2.1.1 Valsartan
2.1.2 Telmisartan
2.1.3 Losartan
2.1.4 Irbesartan
2.1.5 Azilsartan
2.1.6 Olmesartan
2.2 Global Angiotensin Receptor Blockers (ARBs) Market Size by Type
2.2.1 Global Angiotensin Receptor Blockers (ARBs) Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Angiotensin Receptor Blockers (ARBs) Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Angiotensin Receptor Blockers (ARBs) Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Angiotensin Receptor Blockers (ARBs) Market Size by Type
2.3.1 United States Angiotensin Receptor Blockers (ARBs) Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Angiotensin Receptor Blockers (ARBs) Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Angiotensin Receptor Blockers (ARBs) Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 Angiotensin Receptor Blockers (ARBs) Market Segment by Application
3.1.1 Hypertension
3.1.2 Cardiovascular Diseases
3.1.3 Kidney Diseases
3.1.4 Other
3.2 Global Angiotensin Receptor Blockers (ARBs) Market Size by Application
3.2.1 Global Angiotensin Receptor Blockers (ARBs) Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Angiotensin Receptor Blockers (ARBs) Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Angiotensin Receptor Blockers (ARBs) Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Angiotensin Receptor Blockers (ARBs) Market Size by Application
3.3.1 United States Angiotensin Receptor Blockers (ARBs) Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Angiotensin Receptor Blockers (ARBs) Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Angiotensin Receptor Blockers (ARBs) Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Angiotensin Receptor Blockers (ARBs) Competitor Landscape by Company
4.1 Global Angiotensin Receptor Blockers (ARBs) Market Size by Company
4.1.1 Top Global Angiotensin Receptor Blockers (ARBs) Manufacturers Ranked by Revenue (2021)
4.1.2 Global Angiotensin Receptor Blockers (ARBs) Revenue by Manufacturer (2017-2022)
4.1.3 Global Angiotensin Receptor Blockers (ARBs) Sales by Manufacturer (2017-2022)
4.1.4 Global Angiotensin Receptor Blockers (ARBs) Price by Manufacturer (2017-2022)
4.2 Global Angiotensin Receptor Blockers (ARBs) Concentration Ratio (CR)
4.2.1 Angiotensin Receptor Blockers (ARBs) Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Angiotensin Receptor Blockers (ARBs) in 2021
4.2.3 Global Angiotensin Receptor Blockers (ARBs) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Angiotensin Receptor Blockers (ARBs) Manufacturing Base Distribution, Product Type
4.3.1 Global Angiotensin Receptor Blockers (ARBs) Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Angiotensin Receptor Blockers (ARBs) Product Type
4.3.3 Date of International Manufacturers Enter into Angiotensin Receptor Blockers (ARBs) Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Angiotensin Receptor Blockers (ARBs) Market Size by Company
4.5.1 Top Angiotensin Receptor Blockers (ARBs) Players in United States, Ranked by Revenue (2021)
4.5.2 United States Angiotensin Receptor Blockers (ARBs) Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Angiotensin Receptor Blockers (ARBs) Sales by Players (2020, 2021 & 2022)
5 Global Angiotensin Receptor Blockers (ARBs) Market Size by Region
5.1 Global Angiotensin Receptor Blockers (ARBs) Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Angiotensin Receptor Blockers (ARBs) Market Size in Volume by Region (2017-2028)
5.2.1 Global Angiotensin Receptor Blockers (ARBs) Sales in Volume by Region: 2017-2022
5.2.2 Global Angiotensin Receptor Blockers (ARBs) Sales in Volume Forecast by Region (2023-2028)
5.3 Global Angiotensin Receptor Blockers (ARBs) Market Size in Value by Region (2017-2028)
5.3.1 Global Angiotensin Receptor Blockers (ARBs) Sales in Value by Region: 2017-2022
5.3.2 Global Angiotensin Receptor Blockers (ARBs) Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Angiotensin Receptor Blockers (ARBs) Market Size YoY Growth 2017-2028
6.1.2 North America Angiotensin Receptor Blockers (ARBs) Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Angiotensin Receptor Blockers (ARBs) Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Angiotensin Receptor Blockers (ARBs) Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Angiotensin Receptor Blockers (ARBs) Market Size YoY Growth 2017-2028
6.3.2 Europe Angiotensin Receptor Blockers (ARBs) Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Angiotensin Receptor Blockers (ARBs) Market Size YoY Growth 2017-2028
6.4.2 Latin America Angiotensin Receptor Blockers (ARBs) Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Angiotensin Receptor Blockers (ARBs) Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Angiotensin Receptor Blockers (ARBs) Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 Pfizer
7.1.1 Pfizer Corporation Information
7.1.2 Pfizer Description and Business Overview
7.1.3 Pfizer Angiotensin Receptor Blockers (ARBs) Sales, Revenue and Gross Margin (2017-2022)
7.1.4 Pfizer Angiotensin Receptor Blockers (ARBs) Products Offered
7.1.5 Pfizer Recent Development
7.2 Novartis
7.2.1 Novartis Corporation Information
7.2.2 Novartis Description and Business Overview
7.2.3 Novartis Angiotensin Receptor Blockers (ARBs) Sales, Revenue and Gross Margin (2017-2022)
7.2.4 Novartis Angiotensin Receptor Blockers (ARBs) Products Offered
7.2.5 Novartis Recent Development
7.3 Merck
7.3.1 Merck Corporation Information
7.3.2 Merck Description and Business Overview
7.3.3 Merck Angiotensin Receptor Blockers (ARBs) Sales, Revenue and Gross Margin (2017-2022)
7.3.4 Merck Angiotensin Receptor Blockers (ARBs) Products Offered
7.3.5 Merck Recent Development
7.4 Astra Zeneca
7.4.1 Astra Zeneca Corporation Information
7.4.2 Astra Zeneca Description and Business Overview
7.4.3 Astra Zeneca Angiotensin Receptor Blockers (ARBs) Sales, Revenue and Gross Margin (2017-2022)
7.4.4 Astra Zeneca Angiotensin Receptor Blockers (ARBs) Products Offered
7.4.5 Astra Zeneca Recent Development
7.5 Jhonson and Johnson
7.5.1 Jhonson and Johnson Corporation Information
7.5.2 Jhonson and Johnson Description and Business Overview
7.5.3 Jhonson and Johnson Angiotensin Receptor Blockers (ARBs) Sales, Revenue and Gross Margin (2017-2022)
7.5.4 Jhonson and Johnson Angiotensin Receptor Blockers (ARBs) Products Offered
7.5.5 Jhonson and Johnson Recent Development
7.6 Eli Lilly
7.6.1 Eli Lilly Corporation Information
7.6.2 Eli Lilly Description and Business Overview
7.6.3 Eli Lilly Angiotensin Receptor Blockers (ARBs) Sales, Revenue and Gross Margin (2017-2022)
7.6.4 Eli Lilly Angiotensin Receptor Blockers (ARBs) Products Offered
7.6.5 Eli Lilly Recent Development
7.7 Sanofi
7.7.1 Sanofi Corporation Information
7.7.2 Sanofi Description and Business Overview
7.7.3 Sanofi Angiotensin Receptor Blockers (ARBs) Sales, Revenue and Gross Margin (2017-2022)
7.7.4 Sanofi Angiotensin Receptor Blockers (ARBs) Products Offered
7.7.5 Sanofi Recent Development
7.8 Bristol-Myers Squibb
7.8.1 Bristol-Myers Squibb Corporation Information
7.8.2 Bristol-Myers Squibb Description and Business Overview
7.8.3 Bristol-Myers Squibb Angiotensin Receptor Blockers (ARBs) Sales, Revenue and Gross Margin (2017-2022)
7.8.4 Bristol-Myers Squibb Angiotensin Receptor Blockers (ARBs) Products Offered
7.8.5 Bristol-Myers Squibb Recent Development
7.9 Bayer
7.9.1 Bayer Corporation Information
7.9.2 Bayer Description and Business Overview
7.9.3 Bayer Angiotensin Receptor Blockers (ARBs) Sales, Revenue and Gross Margin (2017-2022)
7.9.4 Bayer Angiotensin Receptor Blockers (ARBs) Products Offered
7.9.5 Bayer Recent Development
7.10 GSK
7.10.1 GSK Corporation Information
7.10.2 GSK Description and Business Overview
7.10.3 GSK Angiotensin Receptor Blockers (ARBs) Sales, Revenue and Gross Margin (2017-2022)
7.10.4 GSK Angiotensin Receptor Blockers (ARBs) Products Offered
7.10.5 GSK Recent Development
7.11 Teva Pharmaceutical
7.11.1 Teva Pharmaceutical Corporation Information
7.11.2 Teva Pharmaceutical Description and Business Overview
7.11.3 Teva Pharmaceutical Angiotensin Receptor Blockers (ARBs) Sales, Revenue and Gross Margin (2017-2022)
7.11.4 Teva Pharmaceutical Angiotensin Receptor Blockers (ARBs) Products Offered
7.11.5 Teva Pharmaceutical Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Angiotensin Receptor Blockers (ARBs) Industry Chain Analysis
8.2 Angiotensin Receptor Blockers (ARBs) Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Angiotensin Receptor Blockers (ARBs) Distributors
8.3 Angiotensin Receptor Blockers (ARBs) Production Mode & Process
8.4 Angiotensin Receptor Blockers (ARBs) Sales and Marketing
8.4.1 Angiotensin Receptor Blockers (ARBs) Sales Channels
8.4.2 Angiotensin Receptor Blockers (ARBs) Distributors
8.5 Angiotensin Receptor Blockers (ARBs) Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Angiotensin Receptor Blockers (ARBs) CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
Table 2. Angiotensin Receptor Blockers (ARBs) Market Trends
Table 3. Angiotensin Receptor Blockers (ARBs) Market Drivers
Table 4. Angiotensin Receptor Blockers (ARBs) Market Challenges
Table 5. Angiotensin Receptor Blockers (ARBs) Market Restraints
Table 6. Global Angiotensin Receptor Blockers (ARBs) Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Angiotensin Receptor Blockers (ARBs) Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Angiotensin Receptor Blockers (ARBs) Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Angiotensin Receptor Blockers (ARBs) Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Angiotensin Receptor Blockers (ARBs) Manufacturers in Global Market, Ranking by Revenue (2021)
Table 11. Global Angiotensin Receptor Blockers (ARBs) Revenue by Manufacturer, (US$ Million), 2017-2022
Table 12. Global Angiotensin Receptor Blockers (ARBs) Revenue Share by Manufacturer, 2017-2022
Table 13. Global Angiotensin Receptor Blockers (ARBs) Sales by Manufacturer, (K MT), 2017-2022
Table 14. Global Angiotensin Receptor Blockers (ARBs) Sales Share by Manufacturer, 2017-2022
Table 15. Global Angiotensin Receptor Blockers (ARBs) Price by Manufacturer (2017-2022) & (USD/Unit)
Table 16. Global Angiotensin Receptor Blockers (ARBs) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Angiotensin Receptor Blockers (ARBs) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Angiotensin Receptor Blockers (ARBs) as of 2021)
Table 18. Top Players of Angiotensin Receptor Blockers (ARBs) in Global Market, Headquarters and Distribution of Producing Region
Table 19. Manufacturers Angiotensin Receptor Blockers (ARBs) Product Type
Table 20. Date of International Manufacturers Enter into Angiotensin Receptor Blockers (ARBs) Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Top Angiotensin Receptor Blockers (ARBs) Players in United States Market, Ranking by Revenue (2021)
Table 23. United States Angiotensin Receptor Blockers (ARBs) Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 24. United States Angiotensin Receptor Blockers (ARBs) Revenue Share by Players, 2020, 2021 & 2022
Table 25. United States Angiotensin Receptor Blockers (ARBs) Sales by Players, (K MT), 2020, 2021 & 2022
Table 26. United States Angiotensin Receptor Blockers (ARBs) Sales Share by Players, 2020, 2021 & 2022
Table 27. Global Angiotensin Receptor Blockers (ARBs) Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 28. Global Angiotensin Receptor Blockers (ARBs) Sales in Volume by Region (2017-2022) & (K MT)
Table 29. Global Angiotensin Receptor Blockers (ARBs) Sales in Volume Forecast by Region (2023-2028) & (K MT)
Table 30. Global Angiotensin Receptor Blockers (ARBs) Sales in Value by Region (2017-2022) & (US$ Million)
Table 31. Global Angiotensin Receptor Blockers (ARBs) Sales in Value Forecast by Region (2023-2028) & (US$ Million)
Table 32. North America Angiotensin Receptor Blockers (ARBs) Sales in Volume by Country (2017-2028) & (K MT)
Table 33. North America Angiotensin Receptor Blockers (ARBs) Sales in Value by Country (2017-2028) & (US$ Million)
Table 34. Asia Pacific Angiotensin Receptor Blockers (ARBs) Sales in Volume by Region (2017-2028) & (K MT)
Table 35. Asia Pacific Angiotensin Receptor Blockers (ARBs) Sales in Value by Region (2017-2028) & (US$ Million)
Table 36. Europe Angiotensin Receptor Blockers (ARBs) Sales in Volume by Country (2017-2028) & (K MT)
Table 37. Europe Angiotensin Receptor Blockers (ARBs) Sales in Value by Country (2017-2028) & (US$ Million)
Table 38. Latin America Angiotensin Receptor Blockers (ARBs) Sales in Volume by Country (2017-2028) & (K MT)
Table 39. Latin Americaa Angiotensin Receptor Blockers (ARBs) Sales in Value by Country (2017-2028) & (US$ Million)
Table 40. Middle East and Africa Angiotensin Receptor Blockers (ARBs) Sales in Volume by Country (2017-2028) & (K MT)
Table 41. Middle East and Africa Angiotensin Receptor Blockers (ARBs) Sales in Value by Country (2017-2028) & (US$ Million)
Table 42. Pfizer Corporation Information
Table 43. Pfizer Description and Business Overview
Table 44. Pfizer Angiotensin Receptor Blockers (ARBs) Sales (K MT), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 45. Pfizer Angiotensin Receptor Blockers (ARBs) Product
Table 46. Pfizer Recent Development
Table 47. Novartis Corporation Information
Table 48. Novartis Description and Business Overview
Table 49. Novartis Angiotensin Receptor Blockers (ARBs) Sales (K MT), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 50. Novartis Product
Table 51. Novartis Recent Development
Table 52. Merck Corporation Information
Table 53. Merck Description and Business Overview
Table 54. Merck Angiotensin Receptor Blockers (ARBs) Sales (K MT), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 55. Merck Product
Table 56. Merck Recent Development
Table 57. Astra Zeneca Corporation Information
Table 58. Astra Zeneca Description and Business Overview
Table 59. Astra Zeneca Angiotensin Receptor Blockers (ARBs) Sales (K MT), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 60. Astra Zeneca Product
Table 61. Astra Zeneca Recent Development
Table 62. Jhonson and Johnson Corporation Information
Table 63. Jhonson and Johnson Description and Business Overview
Table 64. Jhonson and Johnson Angiotensin Receptor Blockers (ARBs) Sales (K MT), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 65. Jhonson and Johnson Product
Table 66. Jhonson and Johnson Recent Development
Table 67. Eli Lilly Corporation Information
Table 68. Eli Lilly Description and Business Overview
Table 69. Eli Lilly Angiotensin Receptor Blockers (ARBs) Sales (K MT), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 70. Eli Lilly Product
Table 71. Eli Lilly Recent Development
Table 72. Sanofi Corporation Information
Table 73. Sanofi Description and Business Overview
Table 74. Sanofi Angiotensin Receptor Blockers (ARBs) Sales (K MT), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 75. Sanofi Product
Table 76. Sanofi Recent Development
Table 77. Bristol-Myers Squibb Corporation Information
Table 78. Bristol-Myers Squibb Description and Business Overview
Table 79. Bristol-Myers Squibb Angiotensin Receptor Blockers (ARBs) Sales (K MT), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 80. Bristol-Myers Squibb Product
Table 81. Bristol-Myers Squibb Recent Development
Table 82. Bayer Corporation Information
Table 83. Bayer Description and Business Overview
Table 84. Bayer Angiotensin Receptor Blockers (ARBs) Sales (K MT), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 85. Bayer Product
Table 86. Bayer Recent Development
Table 87. GSK Corporation Information
Table 88. GSK Description and Business Overview
Table 89. GSK Angiotensin Receptor Blockers (ARBs) Sales (K MT), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 90. GSK Product
Table 91. GSK Recent Development
Table 92. Teva Pharmaceutical Corporation Information
Table 93. Teva Pharmaceutical Description and Business Overview
Table 94. Teva Pharmaceutical Angiotensin Receptor Blockers (ARBs) Sales (K MT), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 95. Teva Pharmaceutical Product
Table 96. Teva Pharmaceutical Recent Development
Table 97. Key Raw Materials Lists
Table 98. Raw Materials Key Suppliers Lists
Table 99. Angiotensin Receptor Blockers (ARBs) Customers List
Table 100. Angiotensin Receptor Blockers (ARBs) Distributors List
Table 101. Research Programs/Design for This Report
Table 102. Key Data Information from Secondary Sources
Table 103. Key Data Information from Primary Sources
List of Figures
Figure 1. Angiotensin Receptor Blockers (ARBs) Product Picture
Figure 2. Global Angiotensin Receptor Blockers (ARBs) Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Angiotensin Receptor Blockers (ARBs) Market Size 2017-2028 (US$ Million)
Figure 4. Global Angiotensin Receptor Blockers (ARBs) Sales 2017-2028 (K MT)
Figure 5. United States Angiotensin Receptor Blockers (ARBs) Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 6. United States Angiotensin Receptor Blockers (ARBs) Market Size 2017-2028 (US$ Million)
Figure 7. United States Angiotensin Receptor Blockers (ARBs) Sales 2017-2028 (K MT)
Figure 8. United States Angiotensin Receptor Blockers (ARBs) Market Share in Global, in Value (US$ Million) 2017-2028
Figure 9. United States Angiotensin Receptor Blockers (ARBs) Market Share in Global, in Volume (K MT) 2017-2028
Figure 10. Angiotensin Receptor Blockers (ARBs) Report Years Considered
Figure 11. Product Picture of Valsartan
Figure 12. Product Picture of Telmisartan
Figure 13. Product Picture of Losartan
Figure 14. Product Picture of Irbesartan
Figure 15. Product Picture of Azilsartan
Figure 16. Product Picture of Olmesartan
Figure 17. Global Angiotensin Receptor Blockers (ARBs) Market Share by Type in 2022 & 2028
Figure 18. Global Angiotensin Receptor Blockers (ARBs) Sales in Value by Type (2017-2028) & (US$ Million)
Figure 19. Global Angiotensin Receptor Blockers (ARBs) Sales Market Share in Value by Type (2017-2028)
Figure 20. Global Angiotensin Receptor Blockers (ARBs) Sales by Type (2017-2028) & (K MT)
Figure 21. Global Angiotensin Receptor Blockers (ARBs) Sales Market Share in Volume by Type (2017-2028)
Figure 22. Global Angiotensin Receptor Blockers (ARBs) Price by Type (2017-2028) & (USD/Unit)
Figure 23. United States Angiotensin Receptor Blockers (ARBs) Market Share by Type in 2022 & 2028
Figure 24. United States Angiotensin Receptor Blockers (ARBs) Sales in Value by Type (2017-2028) & (US$ Million)
Figure 25. United States Angiotensin Receptor Blockers (ARBs) Sales Market Share in Value by Type (2017-2028)
Figure 26. United States Angiotensin Receptor Blockers (ARBs) Sales by Type (2017-2028) & (K MT)
Figure 27. United States Angiotensin Receptor Blockers (ARBs) Sales Market Share in Volume by Type (2017-2028)
Figure 28. United States Angiotensin Receptor Blockers (ARBs) Price by Type (2017-2028) & (USD/Unit)
Figure 29. Product Picture of Hypertension
Figure 30. Product Picture of Cardiovascular Diseases
Figure 31. Product Picture of Kidney Diseases
Figure 32. Product Picture of Other
Figure 33. Global Angiotensin Receptor Blockers (ARBs) Market Share by Application in 2022 & 2028
Figure 34. Global Angiotensin Receptor Blockers (ARBs) Sales in Value by Application (2017-2028) & (US$ Million)
Figure 35. Global Angiotensin Receptor Blockers (ARBs) Sales Market Share in Value by Application (2017-2028)
Figure 36. Global Angiotensin Receptor Blockers (ARBs) Sales by Application (2017-2028) & (K MT)
Figure 37. Global Angiotensin Receptor Blockers (ARBs) Sales Market Share in Volume by Application (2017-2028)
Figure 38. Global Angiotensin Receptor Blockers (ARBs) Price by Application (2017-2028) & (USD/Unit)
Figure 39. United States Angiotensin Receptor Blockers (ARBs) Market Share by Application in 2022 & 2028
Figure 40. United States Angiotensin Receptor Blockers (ARBs) Sales in Value by Application (2017-2028) & (US$ Million)
Figure 41. United States Angiotensin Receptor Blockers (ARBs) Sales Market Share in Value by Application (2017-2028)
Figure 42. United States Angiotensin Receptor Blockers (ARBs) Sales by Application (2017-2028) & (K MT)
Figure 43. United States Angiotensin Receptor Blockers (ARBs) Sales Market Share in Volume by Application (2017-2028)
Figure 44. United States Angiotensin Receptor Blockers (ARBs) Price by Application (2017-2028) & (USD/Unit)
Figure 45. North America Angiotensin Receptor Blockers (ARBs) Sales in Volume Growth Rate 2017-2028 (K MT)
Figure 46. North America Angiotensin Receptor Blockers (ARBs) Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 47. U.S. Angiotensin Receptor Blockers (ARBs) Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 48. Canada Angiotensin Receptor Blockers (ARBs) Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 49. Europe Angiotensin Receptor Blockers (ARBs) Sales in Volume Growth Rate 2017-2028 (K MT)
Figure 50. Europe Angiotensin Receptor Blockers (ARBs) Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 51. Germany Angiotensin Receptor Blockers (ARBs) Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 52. France Angiotensin Receptor Blockers (ARBs) Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 53. U.K. Angiotensin Receptor Blockers (ARBs) Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 54. Italy Angiotensin Receptor Blockers (ARBs) Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 55. Russia Angiotensin Receptor Blockers (ARBs) Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 56. Asia-Pacific Angiotensin Receptor Blockers (ARBs) Sales in Volume Growth Rate 2017-2028 (K MT)
Figure 57. Asia-Pacific Angiotensin Receptor Blockers (ARBs) Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 58. China Angiotensin Receptor Blockers (ARBs) Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 59. Japan Angiotensin Receptor Blockers (ARBs) Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 60. South Korea Angiotensin Receptor Blockers (ARBs) Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 61. India Angiotensin Receptor Blockers (ARBs) Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 62. Australia Angiotensin Receptor Blockers (ARBs) Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 63. Taiwan Angiotensin Receptor Blockers (ARBs) Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 64. Indonesia Angiotensin Receptor Blockers (ARBs) Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 65. Thailand Angiotensin Receptor Blockers (ARBs) Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 66. Malaysia Angiotensin Receptor Blockers (ARBs) Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 67. Philippines Angiotensin Receptor Blockers (ARBs) Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 68. Latin America Angiotensin Receptor Blockers (ARBs) Sales in Volume Growth Rate 2017-2028 (K MT)
Figure 69. Latin America Angiotensin Receptor Blockers (ARBs) Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 70. Mexico Angiotensin Receptor Blockers (ARBs) Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 71. Brazil Angiotensin Receptor Blockers (ARBs) Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 72. Argentina Angiotensin Receptor Blockers (ARBs) Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 73. Middle East & Africa Angiotensin Receptor Blockers (ARBs) Sales in Volume Growth Rate 2017-2028 (K MT)
Figure 74. Middle East & Africa Angiotensin Receptor Blockers (ARBs) Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 75. Turkey Angiotensin Receptor Blockers (ARBs) Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 76. Saudi Arabia Angiotensin Receptor Blockers (ARBs) Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 77. U.A.E Angiotensin Receptor Blockers (ARBs) Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 78. Angiotensin Receptor Blockers (ARBs) Value Chain
Figure 79. Angiotensin Receptor Blockers (ARBs) Production Process
Figure 80. Channels of Distribution
Figure 81. Distributors Profiles
Figure 82. Bottom-up and Top-down Approaches for This Report
Figure 83. Data Triangulation
Figure 84. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Pfizer Novartis Merck Astra Zeneca Jhonson and Johnson Eli Lilly Sanofi Bristol-Myers Squibb Bayer GSK Teva Pharmaceutical